ALX Oncology
ALXO
ALXO
75 hedge funds and large institutions have $258M invested in ALX Oncology in 2023 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 26 increasing their positions, 18 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
3.45% less ownership
Funds ownership: 87.37% → 83.91% (-3.5%)
13% less funds holding
Funds holding: 86 → 75 (-11)
50% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 22
Holders
75
Holding in Top 10
1
Calls
$739K
Puts
$86K
Top Buyers
| 1 | +$5.23M | |
| 2 | +$902K | |
| 3 | +$533K | |
| 4 |
Renaissance Technologies
New York
|
+$420K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$364K |
Top Sellers
| 1 | -$3.75M | |
| 2 | -$3.01M | |
| 3 | -$1.92M | |
| 4 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$1.19M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.15M |